---
title: Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium
  on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary
  Disease in Clinical Practice in England
date: '2023-09-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37731774/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230921191728&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: UMEC/VI demonstrated non-inferiority to IND/GLY in moderate-to-severe
  exacerbation reduction at 6, 12 and 18 months. These results support previous findings
  demonstrating similarity between UMEC/VI and IND/GLY on reduction of moderate-to-severe
  ...'
disable_comments: true
---
CONCLUSION: UMEC/VI demonstrated non-inferiority to IND/GLY in moderate-to-severe exacerbation reduction at 6, 12 and 18 months. These results support previous findings demonstrating similarity between UMEC/VI and IND/GLY on reduction of moderate-to-severe ...